跳至主要内容
临床试验/NCT06056869
NCT06056869招募中不适用

Effect of Hyoscine- Bromide on Duration of the First Stage of Labor

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年9月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
duration of first stage of labor

研究概览

简要总结

Spasmolytic drugs are frequently used in delivery rooms to overcome cervical spasms and thus reduce the duration of labor. The aim of this randomized double blind placebo controlled trial is to study the efficacy of hyoscine butylbromide (HBB) for shortening of the first stage of labor in primigravid women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Primigravid women.
  • Singleton pregnancy.
  • Presenting by the vertex.
  • Gestational age between 37 and 42 weeks
  • In active phase of labor with a cervical dilatation between 4-5 cm, with either intact membranes or spontaneous rupture of membranes for less than 12 h

排除标准

  • Previous uterine scarring.
  • Malpresentation.
  • Antepartum hemorrhage.
  • Labor induction
  • Contraindication to vaginal delivery.
  • Contraindication to hyoscine.

研究组 & 干预措施

buscopan group

Active Comparator

will receive 2 ml (40 mg) of hyoscine butylbromide

干预措施: hyoscine butylbromide (Drug)

control group

Placebo Comparator

will receive 2 ml of normal saline

干预措施: normal saline (Other)

结局指标

主要结局

duration of first stage of labor

时间窗: 6 months

duration

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验